ArticlePDF AvailableLiterature Review

Leiomyosarcoma of the Spermatic Cord with Scalp Metastasis: Case Report and Literature Review

Authors:
  • Medical school, University of Zagreb

Abstract and Figures

A B S T R A C T Herein we present 82-year-old man with leiomyosarcoma arising from the spermatic cord with scalp metastasis, five years after primary surgical treatment. Complete surgical excision is required in such cases, as well as precise evaluation of further therapy. Paratesticular leiomyosarcoma is a rare entity, malignant mesenchimal tumor of smooth muscle dif-ferentiation. Although leiomyosarcomas of different localizations have well-known metastatic potential, cutaneous meta-stases are extremely rare with only 16 cases described in the literature. To our knowledge there are no reported cases of the paratesticular leiomyosarcoma metastatic to the skin. This article reviews the literature regarding paratesticular leiomyosarcoma presentation, diagnosis and treatment.
Content may be subject to copyright.
Coll. Antropol. 38 (2014) 2: 763–766
Case report
Leiomyosarcoma of the Spermatic Cord with Scalp
Metastasis: Case Report and Literature Review
[oip [oipi
1
, Majda Vu~i}
2,3
, Monika Ulamec
2,3
, Davor Tomas
2,3
, Bo`o Kru{lin
2,3
and Borislav Spaji}
1,3
1
University of Zagreb, University Hospital Centre »Sestre Milosrdnice«, Department of Urology, Zagreb, Croatia
2
University of Zagreb, University Hospital Centre »Sestre Milosrdnice«, Department of Pathology, Zagreb, Croatia
3
University of Zagreb, School of Medicine, Zagreb, Croatia
ABSTRACT
Herein we present 82-year-old man with leiomyosarcoma arising from the spermatic cord with scalp metastasis, five
years after primary surgical treatment. Complete surgical excision is required in such cases, as well as precise evaluation
of further therapy. Paratesticular leiomyosarcoma is a rare entity, malignant mesenchimal tumor of smooth muscle dif-
ferentiation. Although leiomyosarcomas of different localizations have well-known metastatic potential, cutaneous meta-
stases are extremely rare with only 16 cases described in the literature. To our knowledge there are no reported cases of
the paratesticular leiomyosarcoma metastatic to the skin. This article reviews the literature regarding paratesticular
leiomyosarcoma presentation, diagnosis and treatment.
Key words: spermatic cord tumors, leiomyosarcoma, metastases, skin
Introduction
Primary spermatic cord and paratesticular tumors
are rare yet clinically significant urologic lesions that af-
fect patients of all ages
1
. Their true incidence has actu-
ally never been established. Most tumors are benign,
usually lipomas. Approximately 25% of primary sper-
matic cord tumors are sarcomas originating from the
mesoderm layer of the embryo (Wolffian duct)
2
. Among
the paratesticular sarcomas, leiomyosarcoma is the sec-
ond most common sarcoma in frequency proceeded by
liposarcoma. Tumors in this region generally present as
asymptomatic, slow growing, firm and palpable para-
testicular masses. Radical inguinal orchiectomy and high
ligation of the cord is the standard primary surgical pro-
cedure. The extent of surrounding soft tissue excision is
required and the role of adjuvant radiotherapy remains
controversial. There is not much data in the literature
about this issue. Although leiomyosarcoma has well-
-known metastatic potential, skin metastases are re-
markably uncommon
3
. We report a leiomyosarcoma of
the spermatic cord in an 82-year-old man who developed
scalp cutaneous metastases five years after diagnosis of
primary tumor.
Case Report
82-year-old man presented with 9-month history of
enlarged inguinal region. Patient complained on inter-
mittent abdominal pain. He denied any history of trauma
and any lower urinary tract symptoms, 10 years ago pa-
tient operated on both sided groin hernias. Ultrasonogra-
phic scan revealed normal left testicle and extrates-
ticular, well circumscribed large mass of heterogeneous
echogenicity with prominent vascularity in the left groin
region. Computed tomography of abdomen and pelvis
with intravenous contrast revealed oval, solid, contrast
enhacement tumor mass with central calcifications (Fig-
ure 1a). Retroperitoneal and ingvinal lymph nodes were
not enlarged. Levels of a-fetoprotein and b human chori-
onic gonadotropin were within normal limits, as were re-
sults of routine blood investigations. Plain chest X-ray
was normal.
The physical examination of the scrotum and ingui-
num showed a large, oval, non tender, firm mass mea-
sured up to 10 cm in diametar. A radical left orhiedec-
tomy with high cord ligation and tumor extirpation was
performed. On gross examination the resected specimen
showed lobulated, oval tumor mass attached to sper
-
763
Received for publication January 7, 2014
matic cord that measured 12.5x8.5x6.5 cm (Figure 1b).
Cut surface of tumor was gray, firm and whorled. The tu-
mor mass was completely located outside the tunica
albuginea, not infiltrative to testis or epididymis. Micro-
scopic examination revealed a tumor composed of slen-
der, elongated tumor cells arranged in interlacing fasci-
cles. Tumor cells showed marked nuclear pleomorphism
and up to 10 mitoses per 10-high power fields, without
necrosis (Figure 1c). The testis and epididymis were free
of tumor. Immunohistochemistry revealed positive stain-
ing of tumor cells for smooth muscle actin (SMA) (Figure
1d) and negative for S100. The histology and immuno-
histochemical findings were diagnostic of leiomyosar-
coma. Postoperative course was uneventful and the pa-
tient received no adjuvant therapy. During regular follow
up, 5 years after initial presentation, clinical examina-
tion revealed nodule measuring up to 2 cm in diameter,
on the skull skin. Patient underwent excision biopsy and
microscopic examination showed a well circumscribed
dermal nodule, on high-power it was cellular tumor com-
posed of atypical spindled cells with a woven, lobulated
histological pattern and a high mitotic ratio. Further
immunohistochemical staining was positive for SMA and
confirmed the diagnosis of metastatic leiomyosarcoma.
One month later staging computer tomography of the
chest and abdomen showed multiple lung metastases.
Regarding patient’s age he didn’t receive any adjacent
chemo or radiotherapy and after 3 months is still alive.
Discussion
Leiomyosarcoma is a rare testicular and paratesti
-
cular neoplasm, with about 110 cases reported
4
. There
have been other reports of leiomyosarcoma in the genito-
urinary system, including urethra, renal capsule and
epididymis. These tumors have a higher incidence after
the sixth decade of life
4
. Although the exact origin is un-
known, it is speculated that they most likely originate
from the smooth muscle of different cord structure areas,
such as the vas deferens, canal wall, blood vessels and
cremasteric muscle
5
. Some authors suggested that leio-
myosarcomas of spermatic cord arise as a result of malig-
nant degeneration from previously existing benign leio-
myomatous tumors
5,6
. The role of hormonal stimulation
has also been linked to leiomyosarcoma carcinogenesis.
Interestingly, some spermatic cord leiomyosarcomas
have been found to produce b human chorionic gonado-
tropin causing a paraneoplastic syndrome
6,7
.
Most spermatic cord malignancies originate just be-
low the external inguinal ring and grow as scrotal rather
than inguinal masses. Since they may appear as scrotal
masses, the preoperative clinical diagnosis may be chal-
lenging given that it may be difficult to determine the exact
location of the tumor. Paratesticular sarcomas usually
have a heterogeneous pattern and are seen as hyper-
vascular tumors on Doppler sonography
8
. Computed to-
mography scan and magnetic resonance imaging may be
helpful in refining tumor location, morphologic features,
and tissue characteristics, as well as determining the ex-
tent of the mass into the neighboring tissues. Computed
tomography is helpful in distinguishing a primary sper
-
matic cord tumor from a retroperitoneal process extend
-
ing into the scrotum
8–10
.
Leiomyosarcoma of the cord structures are known to
spread by local invasion, lymphatic dissemination and
[. [oipi et al.: Leiomyosarcoma of the Spermatic Cord, Coll. Antropol. 38 (2014) 2: 763–766
764
Fig. 1. a) CT scan, paratesticular, relatively well circumscribed tumor, up to 9 cm. b) Macroscopic view of the funicular
tumor. c) Microscopically, sheets and cords of polymorphous spindle shaped cells, (100xHE). d) Immunohistochemically
tumor cells are positive for smooth muscule actin (40xSMA).
hematogenous metastases. The route of lymphatic spread
involves the external iliac, hypogastric, common iliac and
paraaortal nodes. Lung is the most common metastatic
site and is almost always involved in metastatic disease.
The curative treatment of choice is radical orchiectomy
with high cord ligation and wide excision of surrounding
soft tissue structures within the inguinal canal. Patients
with inadequately resected tumor should undergo re-
operative procedure for wide inguinal re-excision. It has
been estimated that approximately 50% of these tumors
recur loco-regionally following definitive surgery. Patho-
logic features that convey a higher risk of local recur-
rence include large tumor size, inguinal location, narrow
or positive margins and prior intralesional surgery. Loco-
-regional relapse may occur in the cord, scrotum, or adja-
cent pelvis, with or without involvement of the regional
lymph nodes
1–6
.
Retroperitoneal lymph node dissection is not regu-
larly recommended for patients with spermatic cord leio-
myosarcoma. Retroperitoneal lymphadenectomy is rec-
ommended when there is preoperative evidence of retro-
peritoneal lymph node metastases. Adjuvant treatments,
such as radiotherapy and chemotherapy, have shown lit-
tle efficacy, except in the management of patients with lo-
cal recurrence
10
. Some data suggest that patients who
underwent postsurgical radiotherapy have better prog-
nosis
11
. Our patient underwent radical orchidectomy with
high cord ligation, no further treatment was given. Long-
-term follow up is recommended due to high recurrence
rates. Patients may also present with signs and symp-
toms of distant metastases 15 years or more after first
resection
4,10,11
.
Sarcoma metastases to the skin are rare, in published
literature series reported prevalence was between 1%
and 2.6%. Skin metastases are usually late events in sar-
coma clinical progression and carry a poor prognosis.
Lung metastases may occur in patient either simulta-
neously or within a short period after skin metastases.
The majority of sarcoma patients developed skin me-
tastases distant to the site of primary origin which is in
contrast to many types of carcinomas where regional
skin metastases are common presentation. The scalp is
frequently involved anatomic site, perhaps because of
the highly vascular nature and immobility of this re
-
gion
11
. In the English-spoken literature only 16 cases of
leiomyosarcoma metastatic to the skin have been repor-
ted
3
. The uterus is the overall most common site of origin
metastasizing to the skin. Moreover, primary tumors of
the genitourinary system account for more than half of
the cases. Other sites of primary tumors include gastro-
intestinal tract, heart, breast and the retroperitoneum.
Only one patient in the reported series developed a sin-
gle, isolated skin metastasis. The mean reported interval
between the time of diagnosis of primary leiomyosar-
coma and the development of cutaneous metastases is 3
years
11–13
. To our knowledge there are no reported cases
of the paratesticular leiomyosarcoma metastatic to the
skin.
Prognosis is highly variable, more recently a five-year
survival of 50–80% has been reported, possibly reflecting
the advances in diagnosis and management of these
tumors
13–15
. The wide range in the five-year survival rate
might be due to the variations in tumor stage and grade
at the time of diagnosis as well as the diversity of thera-
pies involved. A recent review disclosed a mean survival
of 138 months for patients with leiomyosarcoma, but the
mean survival after the occurrence of cutaneous meta-
stases in the present series was just 10 months
16
.
Conclusion
Although leiomyosarcoma is a rare neoplasm, it can
present as an extremely large primary tumor. It seems to
have low metastatic potential but metastases may be
seen many years after the primary tumor. Management
is largely surgical. The need for adjuvant therapy is in
question; reports of spermatic cord leiomyosarcoma pro-
vide limited data on postoperative recurrence.
REFERENCES
1. RODRIGUES D, OLUMI AF, Ther Adv Urol, 4 (2012) 325. DOI:
10.1177/1756287212447839 2. FOLPE AL, WEISS SW, Semin Diag Pa-
thol, 17 (2000) 307. 3. VANDERGRIFF T, KRATHEN RA, ORENGO I,
Dermatol Surg, 33 (2007) 634. DOI: 10.1111/j.1524-4725.2007.33127.
4. KYRATZI I, LOLIS E, ANTYPA E, LIANOU MA, EXARHOS D, World
J Radiol, 3 (2011) 114. DOI: 10.4329/wjr.v3.i4.114 5. YUEN VTH, KIR
-
BY SC,WOO YC, Can Urol Assoc J, 5 (2011) 121. DOI: 10.5489/cuaj.11008
6. CELIK U, UNLU G, Asian J Androl, 15 (2013) 843. DOI: 10.1038/
aja.2013.88 7. OU SM, LEE SS, PENG YJ, SHEU NS, CHANG SY, J
Androl, 27 (2013) 643. DOI: 10.2164/jandrol.106.000224. 8. AKBAR
SA, SAYYED TA, JAFRI SZ, HASTEH F, NEILL JS, Radiographics, 23
(2003) 1461. DOI: 10.1148/rg.236025174. 9. WOODWARD PJ,
SCHWAB CM, SESTERHENN IA, Radiographics, 23 (2003) 215. DOI:
10.1148/rg.231025133. 10. VARZANEH FE,VERGHESE M, SHMOO-
KLER BM, Urology, 60 (2002) 1112. DOI: 10.1016/S0090-4295(02)02076-
9. 11. PETERSON AC, PORTER M, PORTER J, Urology, 59 (2002)
294. DOI: 10.1016/S0090-4295(01)01524-2. 12. DANGLE P; BASAVA-
RAJ DR; BHATTARAI S; PAUL AB; BIYANI CS, Can Urol Assoc J, 1
(2007) 55. 13. CORCORAN S, HOGAN AM, NEMETH T, SULLIVAN
FJ, KHAN W, BARRY K, Diagn Pathol, 18 (2012) 85. DOI: 10.1186/1746-
1596-7-85. 14. WANG WL, BONES-VALENTIN RA, PRIETO VG,
POLLOCK RE, LEV DC, LAZAR AJ, Cancer, 118 (2012) 2900. DOI: 10.
1002/cncr.26590. 15. LEE G, LEE SY, SEO S, JEON S, LEE H, CHOI
H, JEONG BC, Korean J Urol, 52 (2011) 669. DOI: 10.4111/kju.2011.52.
10.669. 16. ENOCH S, WHARTON SM, MURRAY DS, World J Surg
Oncol, 3 (2005) 3. DOI: 10.1186/1477-7819-3-23.
[. [oipi et al.: Leiomyosarcoma of the Spermatic Cord, Coll. Antropol. 38 (2014) 2: 763–766
765
B. Spaji}
University of Zagreb, University Hospital Centre »Sestre Milosrdnice«, Department of Urology, Vinogradska 29,
10000 Zagreb, Croatia
e-mail: borislav.spajic@kbcsm.hr
LEIOMIOSARKOM SJEMENOG SNOPA S METASTAZOM U KO@I LUBANJE:
PRIKAZ SLU^AJA I PREGLED LITERATURE
SA@ETAK
Leiomiosarkom paratestikularnog tkiva je veoma rijedak maligni mezenhimalni tumor koji pokazuje glatkomi{i}nu
diferencijaciju. Iako leiomiosarkomi razli~itih sijela imaju dobro poznatu sposobnost metastaziranja, ko`ne metastaze
su izrazito rijetke, sa samo 16 opisanih slu~ajeva u literaturi. Do sada nije opisan nijedan slu~aj metastaze leiomio-
sarkoma sjemenog snopa s metastazama u ko`u. Donosimo opis 82-godi{njeg bolesnika s bezbolnom masom u lijevom
hemiskrotumu, leiomiosarkom sjemenog snopa s metastatskom bolesti koja se manifestirala nakon pet godina kao
ko`ni tumor te zatim i metastazama u plu}a. U takvim slu~ajevima potrebno je potpuno kirur{ko odstranjenje tumor-
ske mase te precizna procjena odre|ivanja daljnje terapije. U ovom radu donosimo prikaz literaturnih navoda koji se
bave opisanom problematikom prezentacije, dijagnoze i lije~enja paratestikularnih leiomiosarkoma.
[. [oipi et al.: Leiomyosarcoma of the Spermatic Cord, Coll. Antropol. 38 (2014) 2: 763–766
766
... The most recent study also reported that there are only about 115 cases of leiomyosarcoma of the spermatic cord in the world literature. [4][5][6][7] This pathological entity in spermatic cord was first reported by Wessel in 1953. [8] All of these reported cases of leiomyosarcoma in spermatic cord are case reports, and there have been no comprehensive studies using many cases. ...
... Only about 115 cases of spermatic cord leiomyosarcoma have been reported in the world literature, and only about 43 cases in the English literature. [4][5][6][7][8][9] Thus, the present case seems important, because the present case adds a case in the lists of spermatic cord leiomyosarcoma. Immunohistochemically, the present tumor was positive for vimentin, α-smooth muscle actin, h-caldesmon, desmin (focal), p53, and Ki-67 antigen (labeling = 34%), but negative for pancytokeratin AE1/3, pancytokeratin CAM5.2, ...
Article
Leiomyosarcoma of spermatic cord is very rare. The patient is 65-year-old man who presented with a tumor in scrotum. Excision of tumor was performed and it showed a solid tumor measuring 4 cm × 3 cm × 3 cm in left spermatic cord. Histologically, it showed proliferation of hypercellular atypical spindle cells with hyperchromatic nuclei. The tumor cells were arranged with fascicles of cigar-shaped spindled cells with scant acidophilic cytoplasm. The tumor was not encapsulated, and mild invasive features into surrounding tissue were noted. The mitotic index was 17; 17 mitotic figures were seen in 10 high-power-fields. Atypical mitosis was also seen. Immunohistochemically, tumor cells were positive for vimentin, α-smooth muscle actin, h-caldesmon,desmin (focal), p53, and Ki-67 (labeling index = 34%). No other tumors were identified in the body, and the patient further treated with auxiliary local radiation and chemotherapy (cisplatin and doxorubicin). He is now healthy and free from tumors in the body 15 months after the operation.
... The specific muscle actin must be positive, as well as the Desmin and not the Vimentin or S 100 Protein, found infat cells. 3,4 From the pathological point of view, it is accepted as a poor prognosis: 1) high cellularity, 2) vascular invasion, 3) necrotic areas, 4) presence of multinucleated cells and 5) mitotic index greater than 2. 5 As definitive treatment, inguinal radical orchiectomy with high ligation of the spermatic cord is accepted. There is no uniformity of criteria at the moment to indicate adjuvant therapy, given the short experience in his treatment. ...
... Most part of metastases are made hematogenously, so that prophylactic irradiation lacks of indication nowadays. 4 ...
Article
Full-text available
Case description of a male patient of 64 years who presents a left groin-scrotum painless tumor, growing, from several months of evolution. Physical examination demonstrated the existence of a mass effect of the left distal spermatic cord, and was later confirmed by ultrasound and CT. Laboratory parameters were normal. The performed surgery consisted in a radical orchiectomy with high ligation of the left cord. In conclusion, preoperative diagnosis of spermatic cord leiomyosarcoma is difficult we need the combination of present illness, physical examination, exams and the gold standard histopathological and immunohistochemical studies allowed a definitive diagnosis.
... 1 Rarely it may present as a cause for limb lymphedema 16 or metastasis to the scalp. 17 The most common mode is lymphatic spread, followed by hematogenous and then local invasion. 14 Lymph nodes and lung fields (for hematogenous spread) are investigated with CT, and local invasion can be explored with magnetic resonance imaging (MRI). ...
Article
Full-text available
Background: The commonest differentials in a case of inguinal swelling are a hernia, hydrocele, lipoma and lymph nodal mass. However, we may come across some rare causes of inguinal lumps such as leiomyosarcoma. This is a case of an elderly gentleman who presented with a history of a painless, progressively enlarging mass over the right inguinal region which on further investigation was found to be a malignant tumour.
... 1 Rarely it may present as a cause for limb lymphedema 16 or metastasis to the scalp. 17 The most common mode is lymphatic spread, followed by hematogenous and then local invasion. 14 Lymph nodes and lung fields (for hematogenous spread) are investigated with CT, and local invasion can be explored with magnetic resonance imaging (MRI). ...
... In very rare cases, LMS can occur in the skin or subcutaneous tissue as metastasis arising from remote, mostly visceral primaries such as uterus [17,18] and retroperitoneum, and also from connective tissue [19] or spermatic cord [20]. Approximately 15 such cases have been recorded in the literature and were referred to as "secondary" LMS. ...
Article
Full-text available
Sarcomas are a heterogeneous group of mesenchymal tumors which can affect bone and soft tissue. Leiomyosarcoma (LMS) is a rare subtype localized to the skin or subcutaneous tissue. Due to the heterogeneity of sarcomas, reviews and guidelines with an in-depth focus specifically on primary LMS of the skin are sparse. This article is intended to provide an up to date and systematic overview on diagnosis, treatment, and surveillance of this rare entity to provide a framework for decision making and management for dermato-oncologists. We discuss novel treatment options for advanced disease such as targeted therapy with kinase inhibitors and immune checkpoint blockade which may improve the prognosis even in advanced stages of LMS.
... Due to the limited number of cases of this rare malignancy, an ideal treatment protocol has yet to be established with most documented treatments currently describing spermatic cord leiomyosarcoma. 15 Long-term follow up is recommended as locoregional recurrence rates are as high as 50%. Patients should be closely monitored for a minimum period of 36 months. ...
... 'Leiomyosarcomas' originate from the smooth muscle cells of mesenchymal origin of different cord structure areas, such as the vas deferens, inguinal canal wall, blood vessels, or cremaster muscle [15 && ]. Although the well differentiated variants may have good prognosis, high-grade tumors often develop metastases and impact severely on survival [16]. Immunohistochemical techniques are needed to confirm the diagnosis of these subtypes. ...
Article
Purpose of review: Spermatic cord tumors (SCT) are very rare. The present review discusses the most recent literature regarding clinical presentation, pathological characteristics, diagnosis, and management of SCT. Recent findings: Although the majority of SCT are benign, when malignant almost all SCT are sarcomas. Liposarcomas are the most common; whereas rhabdomyosarcomas recorded the highest tendency of develop distant metastases. The clinical presentation is usually a unilateral solid slow-growing mass at the level of the inguinal canal and of the scrotum. Surgical excision represents the most common used treatment, and considering the risk in developing local recurrence, radical inguinal orchiectomy and resection of the tumor with negative microscopic surgical margins is mandatory. Adjuvant therapies such as radiotherapy and chemotherapy have been suggested in selected patients, but clear data to demonstrate any improvement in survival are not available. Summary: SCT are rare tumors with high risk of misdiagnosis or mistreatment. The majority are benign, but when malignant almost all are sarcomas. A surgical excision is the treatment of choice; however, no clear data exists documenting the efficacy of a multimodal treatment in reducing high local recurrence rates after surgery.
... Primary paratesticular tumors constitute 7% to 10% of all intrascrotal tumors (2). Generally these tumors present as asymptomatic, firm, palpable, and slow-growing paratesticular masses (3). These type of lesions are reported in all age groups, but are mostly diagnosed in the sixth and seventh decade of life (4). ...
Article
Full-text available
Leiomyosarcoma is a malignant soft tissue tumor that can arise from any tissue containing smooth muscle. Leiomyosarcomas of the spermatic cord are rare tumors of non-testicular origin, which drain into the retroperitoneal lymph nodes and have been reported in less than 150 cases in the literature until now. Radical inguinal orchiectomy and high ligation of the cord is the standard primary surgical procedure in spermatic cord leiomyosarcoma. Here we reported a 75-year-old man who presented with a painless lump in the right hemiscrotum. A right radical orchiectomy was performed. Histopathology confirmed a neoplastic tissue with mesenchymal origin in spermatic cord; further evaluation revealed a leiomyosarcoma of the spermatic cord. The patient was followed up for 1-year and shows no signs of recurrence. Preoperative diagnosis of spermatic cord leiomyosarcma is difficult and commonly made by histological examination and immunochemical staining.
Article
Leiomyosarcoma (LMS) of the skin is rare, and no management guideline currently exists. Although LMS is historically classified as either dermal (cutaneous) or subcutaneous, definition for its classfication is inconsistent in the literature. Studies on the managenent of LMS are scarce, and there is no consensus on the appropriate surgical margin for the treatment of LMS. While a 1 cm margin may be sufficient in cutaneous LMS, wider margins may be required for subcutaneous tumors. Mohs micrographic surgery is a promising surgical modality for the treatment of cutaneous LMS. In this review, current knowledge on LMS is summarized and a practical approach to the management of this rare neoplasm is proposed.
Article
Objectives: To assess the feasibility and the safety of conservative surgery to treat spermatic cord leiomyosarcoma. Methods: Patients undergoing inguinoscrotal exploration in 10 different Urological Centers with diagnosis of leiomyosarcoma were enrolled. Preoperative evaluation included physical examination, Scrotal US, Abdominal CT and Scrotal MRI in selected cases. Patients underwent organ sparing surgery or orchiectomy in case of intraoperative FSE was positive for a local infiltration. Data collected were: age, presence of infiltration, length of the lesion, number of lesions, definitive histological outcome, pre and postoperative testosterone level. Follow up was performed with abdomen CT scan and scrotal US. Results: From January 2007 to December 2013, 23 patients (mean age: 64.7 yrs) were diagnosed with spermatic cord leiomyosarcoma. Each patients underwent scrotal US. 10 patients underwent radical orchiectomy and 13 patients underwent conservative surgery. Mean follow up was 36.5 months. 5 patients (21.7%) developed a recurrent disease, 18 patients (78.3%) had a negative follow up (mean time: 40.8 months). Statistical analysis reveals that there is a significant correlation between number of lesions, length of the lesions and recurrent disease. Conclusions: Spermatic cord leiomyosarcoma is a rare disease. Conservative surgical treatment of spermatic cord leiomyosarcoma is a feasible therapeutic option for small, single and not infiltrating lesion.
Article
Full-text available
Article
Full-text available
Primary spermatic cord tumors are rare yet clinically significant urologic lesions that affect patients of all ages. They are the most common tumors of the paratesticular region and generally present as asymptomatic, slow growing, firm, palpable paratesticular masses. Although most of them are benign comprised primarily of lipomas, approximately 25% are potentially life-threatening malignant tumors. The most common reported malignant histological types include liposarcomas, leiomyosarcomas, rhabdomyosarcomas, malignant fibrous histiocytoma, and fibrosarcomas. Management of these malignant tumors has been difficult because of their rarity, therefore there is little consensus regarding optimal surgical and adjunctive treatment strategies. It is recommended that radiological techniques such as scrotal ultrasound (US), computed tomography, and magnetic resonance be used to evaluate these masses before surgery. The curative treatment of choice is radical orchiectomy with high cord ligation and wide excision of surrounding soft tissue structures within the inguinal canal. Patients with inadequately resected disease should undergo a reoperative procedure for wide inguinal re-resection. Retroperitoneal lymphadenectomy is recommended when there is preoperative evidence of retroperitoneal lymph node metastasis and as an adjuvant treatment for rhabdomyosarcomas since they have a higher propensity for lymphatic spread. Adjuvant treatments, such as radiotherapy and chemotherapy, have shown little efficacy, except in the management of patients with local recurrence or high-grade rhabdomyosarcomas. Long-term follow up is recommended given their high recurrence rates.
Article
Full-text available
A 54 year old lady presented for routine excision of a scalp lesion thought clinically to represent a sebaceous cyst of the right occiput. 4 years earlier she underwent total abdominal hysterectomy and right salpingo-oophorectomy for 3 large uterine fibroids. Histo-pathological examination of the hysterectomy specimen revealed an incidental low-grade leiomyosarcoma. Staging imaging was negative for metastatic disease. She made an uneventful recovery and was treated further by adjuvant pelvic radiotherapy. She noticed an uncomfortable and unsightly cystic swelling on her occiput four years after hysterectomy and was referred for routine excision of what was believed to be a benign lesion. The lesion was excised and sent for histopathological examination. Microscopic analysis including immuno-histochemistry demonstrated an ER and PR positive metastatic deposit of leiomyosarcoma. The margins of excision were histologically clear of disease. At Multi-Disciplinary Team (MDT) discussion a diagnosis of metastatic scalp deposit from previous uterine leiomyosarcoma was made. Re-staging CT brain, thorax, abdomen and pelvis and MRI brain were negative for local recurrence or distant metastases. She is currently undergoing radiotherapy to the scalp and surrounding tissues and will be followed up closely by the involved teams. To the best of our knowledge, this is the first case described in the worldwide literature of isolated cutaneous metastasis to the scalp of uterine leiomyosarcoma without evidence of disseminated disease at other sites. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1311834987345566.
Article
Full-text available
The purpose of this study was to elucidate prognostic factors for survival and clinical outcomes of rological soft tissue sarcomas (STSs). This was a retrospective review of the medical records of 48 patients with urological STS treated from January 1982 to July 2009. Demographic and pathological characteristics were compared. Patients' demographics, clinico-pathological parameters, overall survival, and the factors expected to predict survival, such as sex, age at diagnosis, primary organ, surgical resection, metastasis, and mass size, were analyzed. We evaluated differences in survival on the basis of histological subtype by Kaplan-Meier analysis and multivariate Cox proportional hazards regression. The study included 34 males (70.8%) and 14 females (29.1%). The mean age at diagnosis was 47.1 years (range, 3 to 80). The most common site was the retroperitoneum (n=16), followed by the kidney (n=12), prostate (n=10), bladder (n=7), ureter (n=1), and paratesticular region (n=1). Nineteen patients (39.5%) had other organ metastases at diagnosis. The most common subtypes of sarcoma were leiomyosarcoma (50%), rhabdomyosarcoma (18.7%), and liposarcoma (8%). The remaining 11 cases had other histological subtypes (22.9%). Mean tumor size was 9.5 cm (range, 2.2 to 24). Thirty-three patients (68.7%) underwent surgical resection. The overall survival rate at 5 years was 51.4%. In the univariate and multivariate analysis, surgical resection, primary tumor site, and metastasis at diagnosis remained significant predictors of prognosis. Patients with retroperitoneal sarcoma had a higher overall survival rate by 5 years compared with patients with other organ sarcoma. The overall survival rate at 5 years was 51.4%. Surgical resection, primary tumor site, and metastasis at diagnosis remained significant predictors of prognosis.
Article
Full-text available
Sarcoma metastases to the skin are relatively rare, because most involve the lung, liver, or deep soft tissues. The authors of this report examined the distribution and clinical significance of cutaneous and superficial subcutaneous sarcoma metastases. Sixty-five patients with histologically confirmed dermal and superficial subcutaneous sarcoma metastases were identified in pathology files from more than 25,000 patients with sarcoma who were evaluated at The University of Texas M. D. Anderson Cancer Center from 1989 to 2009. Pathology slides and clinical and radiological information were evaluated. Cutaneous metastases were documented histologically in <0.25% of patients. The mean patient age was 49 years (range, 16-79 years), and there was an equivalent ratio of men to women. The most common source of metastasis was leiomyosarcoma (28 of 65 patients; 43%). The most common region of first skin metastasis was head and neck (33 patients; 51%), and the scalp predominated (25 patients; 38%). The mean time from primary tumor diagnosis to skin metastasis was 48 months (range, 0-166 months). Fifty-three patients (81%) had multiple metastases (skin and other). Among the patients who had complete clinical information available, 31 patients (62%) had other metastases diagnosed before skin involvement, 17 patients (34%) had skin metastases diagnosed first, and 2 patients (4%) had simultaneous presentation. The following clinical outcomes were documented: Twenty-nine patients (45%) died of disease, 24 patients (37%) remained alive with disease, and 12 patients were lost to follow-up. The mean time to death was 80 months (range, 9-224 months) after primary diagnosis, 45 months (range, 5-94 months) after the first metastasis to any site, and 27 months (range, 5-65 months) after the first skin metastasis. Sarcoma metastases to the skin are rare. In this large study, leiomyosarcoma was the most common source, and the scalp was the most frequent site. The majority of patient with skin metastases harbored metastases elsewhere. However, skin was the initial site of metastasis in approximately 1 in 3 patients. Thus, clinical correlation is needed before establishing a diagnosis of primary cutaneous sarcoma, particularly leiomyosarcoma of scalp. Finally, the current results indicated that skin metastasis usually is a late event in sarcoma clinical progression and heralds a poor prognosis.
Article
Full-text available
Spermatic cord leiomyosarcomas (LMSs) are rare tumors which may cause significant morbidity and mortality if inadequately diagnosed or treated. We report a case of a paratesticular LMS in a 60-year-old man who presented with a right scrotal mass. The patient was evaluated by scrotal ultrasound and computed tomography of the abdomen and pelvis (including scans of the scrotum), which revealed a large extratesticular mass. The lesion proved to be malignant and the patient underwent radical orchiectomy with high cord ligation. To improve the assignment of this lesion, we further analyze the imaging features of LMS and correlate them with pathologic findings.
Article
Paratesticular leiomyosarcomas are rare. We report two cases of leiomyosarcoma of the epididymis diagnosed and treated in a regional community hospital in Canada in 2009 and 2010. Both patients were males of ages 58 and 75, respectively. They presented with painless masses which, on ultrasonography, appeared to be solid masses demonstrating blood flow. Each patient underwent trans-scrotal resection of the affected epididymis. Pathological examination of trans-scrotal epididymectomy specimens confirmed the diagnosis of high-grade leiomyosarcoma. Leiomyosarcoma is an important differential diagnosis for paratesticular masses in the elderly male; the primary treatment is radical inguinal orchiectomy with high ligation of the spermatic cord.
Article
Paratesticular soft tissue tumors are uncommon neoplasms that may present significant challenges for the pathologist and clinician. This article reviews the incidence of these rare tumors, and on the common benign and malignant entities that occur in this location. Key points in differential diagnosis are emphasized. The grading, staging, and management of patients with paratesticular sarcomas is also discussed.
Article
Soft tissue tumors, both benign and malignant, of the testes are relatively uncommon. Primary leiomyosarcoma of the testis is rare, and its clinical behavior is difficult to predict. We report a case of paratesticular leiomyosarcoma in a 71-year-old man. Routine histologic examination and immunohistochemical staining were performed. The tumor was composed of interlacing fascicles of smooth muscle cells with marked nuclear pleomorphism and three to four mitoses per high power field, with few atypical mitoses. On the basis of the microscopic examination and immunohistochemical studies, the tumor was identified as a paratesticular leiomyosarcoma. The published studies on this entity are reviewed.